• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » HeartWare jumps after Q1 results beat estimates

HeartWare jumps after Q1 results beat estimates

May 2, 2014 By Brad Perriello

HeartWare jumps after Q1 results beat estimates

HeartWare International (NSDQ:HTWR) shares gained more than 11% yesterday after the medical device company reported surging revenues and 1st-quarter losses that bettered analysts’ forecasts.

HeartWare reported losses of -$19.4 million, or -$1.15 per share, on sales of $66.5 million for the 3 months ended March 31, for sales growth of 35.0% compared with the same period last year. Adjusted to exclude 1-time items, losses per share were -70¢, 20¢ ahead of Wall Street’s consensus estimate.

HTWR shares gained 11.1% yesterday on the news, closing at $94.43 apiece. The stock opened today at $95.14 per share, up 0.8%.

"Reflecting expanded global adoption, our team generated sales of more than 300 units in both the U.S. as well as international markets, for the first time in our history," president & CEO Doug Godshall said in prepared remarks. "We continue to see enthusiastic support of the HeartWare system around the world, with the addition of 12 international and 5 U.S. customers during the first quarter, increasing our global customer base to nearly 250 hospitals."

In a separate release, HeartWare said it notified patients and healthcare providers about an increase in complaints about the batteries used in the HVAD device. No deaths due to faulty batteries have been reported, but 3 deaths between January 2011 and March 31 "were potentially related to power source management," the company said.

"Of those, 2 patient deaths occurred after both sources of power were simultaneously disconnected; the 3rd patient had batteries that far exceeded their expected useful life. A 4th death was originally reported as possibly related to power management, but was later determined to be more likely related to an accidental disconnection of the driveline," according to the release.

Godshall told analysts during a conference call that the correction letter was intended to remind customers about

"The main purpose of the action was to ensure that patients were 1st reminded of what they were trained on when they received the implant, simple things like always have 2 power sources, don’t walk around with 1 battery attached, don’t detach both batteries at the same time – the kind of behaviors that we’ve noticed have led to unfortunate outcomes for a few patients," Godshall said. "And also, given that as time goes on, we all know batteries will sometimes atrophy and we want to make sure its clear that patients understand how to identify a battery that needs to be taken out of service and not inadvertently sort of remove the wrong battery from their controller when that 1 is performing well and be able to identify the 1 that’s not."

Last month HeartWare issued a Class I recall after receiving 8 complaints of failed locking mechanisms in the HVAD’s patient driveline connectors, which connect the implanted circulatory assist device to an external controller that powers and monitors the device. No injuries or deaths related to the issue were reported.

Filed Under: MassDevice Earnings Roundup, News Well, Structural Heart Tagged With: 2014, HeartWare International Inc., Q1

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy